Related Experiment Video
Updated: Jul 18, 2025
10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
9.4K
BH3 Mimetic Peptides: An Effective Strategy to Complement Anticancer Therapy
Sundra Dhakshinamurthy Saraswathy1, Arumugam Mirunalini2, Kandasamy Karthikeyan2
1Department of Biomedical Science, Bharathidasan University, Tiruchirappalli, 620 024, Tamil Nadu, India.
Current Protein & Peptide Science
|August 23, 2023
Summary
Targeting apoptosis, a programmed cell death process, is key for cancer therapy. BH3-peptide mimetics offer a novel approach by antagonizing Bcl-2 proteins to induce cancer cell death.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Therapeutics
Background:
- Apoptosis, or programmed cell death, is crucial for maintaining cellular balance, and its dysregulation is implicated in diseases like cancer.
- Defects in apoptotic pathways, particularly involving the Bcl-2 protein family, contribute to cancer development and chemoresistance.
- The Bcl-2 family regulates mitochondrial apoptosis, with pro-survival and pro-apoptotic members (like Bax/Bak) controlling cell death.
Conclusions:
- BH3-peptide mimetics represent a promising new class of drugs for cancer therapy.
- Targeting Bcl-2 proteins with these mimetics can induce programmed cell death in cancer cells.
- Further development of BH3-peptide mimetics holds significant potential for effective cancer treatment.
Keywords:
BH3 mimeticsBcl-2 antagonistBcl-2 family proteinsapoptosisprogrammed cell death.tumorigenesisMore Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K